Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Verastem Inc.

Start price
Target price
Perf. (%)
€15.65
05.08.20
€36.00
11.08.20
0.00%
11.08.20

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
04.08.20
€38.00
04.11.21
0.31%
13.04.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
GSK plc

Start price
Target price
Perf. (%)
€17.54
01.08.20
€20.00
04.11.21
5.35%
05.11.21

Could be worthwhile Investment >10% per year
Novavax Inc.

Start price
Target price
Perf. (%)
€123.60
31.07.20
-
13.08.20
-15.15%
13.08.20

Achieve Life Sciences Inc.

Start price
Target price
Perf. (%)
€9.61
31.07.20
-
04.11.21
-19.91%
05.11.21

Precipio Inc

Start price
Target price
Perf. (%)
€5.95
30.07.20
€1.00
04.11.21
-65.88%
05.11.21

buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€89.92
30.07.20
€125.00
04.11.21
44.97%
21.01.21

Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
Novavax Inc.

Start price
Target price
Perf. (%)
€110.70
27.07.20
-
04.11.21
50.84%
05.11.21

Revenue growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
High valuation
buy
Evotec SE

Start price
Target price
Perf. (%)
€25.00
23.07.20
-
13.09.20
-8.08%
13.09.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
buy
Valbiotis

Start price
Target price
Perf. (%)
€8.00
19.07.20
€7.50
04.11.21
-11.88%
26.09.21

Could be worthwhile Investment >10% per year
buy
Lannett Co. Inc.

Start price
Target price
Perf. (%)
€21.89
16.07.20
€120.00
04.11.21
-63.45%
05.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth > 30% per year expected
High Investments for future growth
buy
Pharma Mar S.A.

Start price
Target price
Perf. (%)
€137.76
16.07.20
-
01.08.20
-35.60%
01.08.20

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.70
16.07.20
€33.21
25.08.20
4.15%
25.08.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€3.18
15.07.20
-
01.08.20
-36.48%
01.08.20

Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€3.62
14.07.20
-
15.07.20
-12.15%
15.07.20

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.27
14.07.20
€5.85
05.08.20
-5.09%
05.08.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Ipsen S.A.

Start price
Target price
Perf. (%)
€81.00
13.07.20
€95.00
04.11.21
12.32%
05.11.21

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.65
12.07.20
-
17.10.20
9.93%
17.10.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Purple Biotech Ltd. ADR

Start price
Target price
Perf. (%)
€7.10
11.07.20
€6.00
04.11.21
-43.38%
05.11.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
buy
Biocorp Production S.A.

Start price
Target price
Perf. (%)
€25.90
09.07.20
€25.00
04.11.21
11.97%
05.11.21

Could be worthwhile Investment >10% per year
buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€90.75
06.07.20
€80.00
04.11.21
-8.48%
05.11.21

buy
Innoviva Inc.

Start price
Target price
Perf. (%)
€12.30
06.07.20
€17.00
04.11.21
27.64%
05.11.21

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.84
01.07.20
€42.69
08.07.20
-2.30%
08.07.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Baxter International

Start price
Target price
Perf. (%)
€77.61
01.07.20
€80.00
04.11.21
-12.10%
05.11.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
Inovio Pharma

Start price
Target price
Perf. (%)
€25.80
30.06.20
-
04.11.21
-72.73%
17.06.21

Probably not worthwhile Investment